JANX
Janux Therapeutics (JANX)
$10
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$16.39
Daily low
$15.93
Price at open
$15.99
52 Week High
$35.34
52 Week Low
$12.12
Market cap
975.8M
Dividend yield
0.00%
Volume
540,892
Avg. volume
762,129
P/E ratio
-8.69
Janux Therapeutics News
Details
Daily high
$16.39
Daily low
$15.93
Price at open
$15.99
52 Week High
$35.34
52 Week Low
$12.12
Market cap
975.8M
Dividend yield
0.00%
Volume
540,892
Avg. volume
762,129
P/E ratio
-8.69